The Treatment of Hemodialysis Patients' Anemia

Phase 2

• Conditions: Iron Deficiency Anaemia.; Other iron deficiency anaemias, Iron deficiency anaemia, unspecified; D50.8, D50

• Registration Number: IRCT201102195864N1
• Lead Sponsor: Vice chancellor for research, Golestan Medical Sciences University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Receiving hemodialysis therapy for at least 6 months; having dossier in hemodialysis ceneter; three time hemodialysis weekly and four hours for each session; hemoglobin less than 10 g/dl; history of seven weeks treatment with subcutaneous erythropoietin (2000 units, three times weekly at the end of each dialysis sessions).

Exclusion criteria:
Bone marrow malignancy; evidence of chronic infection; evidence of significant bleeding (decrease in Hb level > 2g/dL during the past 3 months); hemoglobinopathies; myelodysplastic syndrome.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin. Timepoint: Pre and Post of Intervention. Method of measurement: Blood Exam.;Ferrtin. Timepoint: Pre and Post of Intervention. Method of measurement: Blood Exam.;Total Iron Bonding Capasity. Timepoint: Pre and Post of Intervention. Method of measurement: Blood Exam.